Notoginsenoside ST-4

Details

Top
Internal ID b32e8b3b-cb96-4a72-bc9e-a04c30613f53
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name (2S,3R,4S,5R)-2-[(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
SMILES (Canonical) CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)O)C
SMILES (Isomeric) CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)C)C)O)C)O)C
InChI InChI=1S/C47H80O17/c1-22(2)10-9-14-47(8,58)23-11-16-46(7)31(23)24(50)18-29-44(5)15-13-30(43(3,4)28(44)12-17-45(29,46)6)62-41-38(35(55)33(53)26(19-48)60-41)64-42-39(36(56)34(54)27(20-49)61-42)63-40-37(57)32(52)25(51)21-59-40/h10,23-42,48-58H,9,11-21H2,1-8H3/t23-,24+,25+,26+,27+,28-,29+,30-,31-,32-,33+,34+,35-,36-,37+,38+,39+,40-,41-,42-,44-,45+,46+,47-/m0/s1
InChI Key LLXVPTXOKTYXHU-HUGMCNGHSA-N
Popularity 3 references in papers

Physical and Chemical Properties

Top
Molecular Formula C47H80O17
Molecular Weight 917.10 g/mol
Exact Mass 916.53955108 g/mol
Topological Polar Surface Area (TPSA) 278.00 Ų
XlogP 2.50
Atomic LogP (AlogP) 0.61
H-Bond Acceptor 17
H-Bond Donor 11
Rotatable Bonds 12

Synonyms

Top
CHEMBL3594359

2D Structure

Top
2D Structure of Notoginsenoside ST-4

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6877 68.77%
Caco-2 - 0.8937 89.37%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.7251 72.51%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7861 78.61%
OATP1B3 inhibitior + 0.8189 81.89%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6000 60.00%
BSEP inhibitior + 0.7881 78.81%
P-glycoprotein inhibitior + 0.7686 76.86%
P-glycoprotein substrate - 0.8127 81.27%
CYP3A4 substrate + 0.7307 73.07%
CYP2C9 substrate - 0.7890 78.90%
CYP2D6 substrate - 0.8406 84.06%
CYP3A4 inhibition - 0.9502 95.02%
CYP2C9 inhibition - 0.8671 86.71%
CYP2C19 inhibition - 0.9036 90.36%
CYP2D6 inhibition - 0.9380 93.80%
CYP1A2 inhibition - 0.9057 90.57%
CYP2C8 inhibition + 0.6559 65.59%
CYP inhibitory promiscuity - 0.9413 94.13%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6474 64.74%
Eye corrosion - 0.9907 99.07%
Eye irritation - 0.9067 90.67%
Skin irritation - 0.5956 59.56%
Skin corrosion - 0.9488 94.88%
Ames mutagenesis - 0.6000 60.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8112 81.12%
Micronuclear - 0.8800 88.00%
Hepatotoxicity - 0.5846 58.46%
skin sensitisation - 0.8991 89.91%
Respiratory toxicity + 0.5111 51.11%
Reproductive toxicity + 0.8889 88.89%
Mitochondrial toxicity - 0.5875 58.75%
Nephrotoxicity - 0.8345 83.45%
Acute Oral Toxicity (c) I 0.5677 56.77%
Estrogen receptor binding + 0.8008 80.08%
Androgen receptor binding + 0.7382 73.82%
Thyroid receptor binding - 0.5548 55.48%
Glucocorticoid receptor binding + 0.6736 67.36%
Aromatase binding + 0.6563 65.63%
PPAR gamma + 0.7751 77.51%
Honey bee toxicity - 0.5377 53.77%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.9172 91.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.92% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.72% 97.25%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 94.92% 95.58%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.10% 97.09%
CHEMBL226 P30542 Adenosine A1 receptor 93.85% 95.93%
CHEMBL241 Q14432 Phosphodiesterase 3A 91.92% 92.94%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.36% 96.09%
CHEMBL2996 Q05655 Protein kinase C delta 89.56% 97.79%
CHEMBL5608 Q16288 NT-3 growth factor receptor 89.43% 95.89%
CHEMBL1994 P08235 Mineralocorticoid receptor 89.25% 100.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 89.18% 86.33%
CHEMBL1937 Q92769 Histone deacetylase 2 89.11% 94.75%
CHEMBL5888 Q99558 Mitogen-activated protein kinase kinase kinase 14 88.63% 100.00%
CHEMBL3714130 P46095 G-protein coupled receptor 6 87.12% 97.36%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 86.27% 92.88%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 85.99% 95.50%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 84.55% 97.14%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 84.54% 94.45%
CHEMBL218 P21554 Cannabinoid CB1 receptor 84.35% 96.61%
CHEMBL1977 P11473 Vitamin D receptor 84.21% 99.43%
CHEMBL2581 P07339 Cathepsin D 83.74% 98.95%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 82.60% 91.24%
CHEMBL1914 P06276 Butyrylcholinesterase 82.02% 95.00%
CHEMBL5028 O14672 ADAM10 81.72% 97.50%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 81.62% 92.62%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 81.52% 100.00%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 80.65% 82.69%

Cross-Links

Top
PubChem 53348538
NPASS NPC194842
ChEMBL CHEMBL3594359